Virtu KCG Holdings’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$71K Buy
331
+110
+50% +$34.1K ﹤0.01% 2512
2017
Q1
$88K Buy
+221
New +$95.4K ﹤0.01% 2715
2016
Q4
Sell
-31
Closed -$31K 3884
2016
Q3
$31K Buy
31
+8
+35% +$8K ﹤0.01% 2870
2016
Q2
$24K Buy
23
+2
+10% +$2.28K ﹤0.01% 2780
2016
Q1
$24K Buy
+21
New +$21.8K ﹤0.01% 2574
2015
Q3
Sell
-5
Closed -$13K 3916
2015
Q2
$13K Sell
5
-1
-17% -$3K ﹤0.01% 3216
2015
Q1
$26K Buy
+6
New +$26.4K ﹤0.01% 2922
2014
Q4
Sell
-7
Closed -$31K 4329
2014
Q3
$31K Sell
7
-11
-61% -$51.3K ﹤0.01% 3423
2014
Q2
$91K Buy
+18
New +$91.3K ﹤0.01% 3321

Other funds holding NURO

Virtu KCG Holdings's NURO Position: Q2 2017 in Review

Virtu KCG Holdings increased its NeuroMetrix, Inc. Common Stock (NURO) stake by 50% in Q2 2017, buying an estimated $34.1K and bringing the position to 331 shares worth $71K. The position accounts for ﹤0.01% of the portfolio, ranked #2512.

Virtu KCG Holdings first reported a position in NURO in Q2 2014 and has held it in 9 quarters since. The position peaked at $91K in Q2 2014. 7 funds tracked by Wall St. Rank hold NURO as of Q2 2017.

  • Virtu KCG Holdings held 331 shares of NeuroMetrix, Inc. Common Stock worth $71K as of Q2 2017.
  • Virtu KCG Holdings bought 110 NeuroMetrix, Inc. Common Stock shares in Q2 2017, an estimated $34.1K.
  • NeuroMetrix, Inc. Common Stock made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2512 holding.
  • Virtu KCG Holdings first reported a position in NeuroMetrix, Inc. Common Stock in Q2 2014 and has held it in 9 quarters since.
  • Virtu KCG Holdings's NeuroMetrix, Inc. Common Stock position peaked at $91K in Q2 2014.
  • 7 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.